AMINONORDECANE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
申请人:Nanjing Transthera Biosciences Co., Ltd.
公开号:EP3858833A1
公开(公告)日:2021-08-04
The present invention relates to a compound of formula I or a pharmaceutically acceptable salt, a solvate, an active metabolite, a polymorph, an ester, an optical isomer or a prodrug thereof, a pharmaceutical composition comprising the compound of formula I, and use of the compound, as a Bruton's tyrosine kinase inhibitor with high selectivity for BTK(C481S) mutant, in the manufacture of a medicament for preventing or treating a heteroimmune disease, an autoimmune disease or a cancer.
本发明涉及一种式 I 的化合物或其药学上可接受的盐、溶液剂、活性代谢物、多晶型物、酯、光学异构体或原药,一种包含式 I 的化合物的药物组合物,以及该化合物作为对 BTK(C481S)突变体具有高选择性的布鲁顿酪氨酸激酶抑制剂在制造预防或治疗异种免疫性疾病、自身免疫性疾病或癌症的药物中的用途。